RET Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update
Genes · 09.12.2025 · 16 (12) · 1472
DOI: 10.3390/genes16121472 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 09.12.2025. Verfasst von Claudio Ricciardi Tenore und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departmental Unit of Molecular and Genomic Diagnostics, Fondazione Policlinico Gemelli IRCCS, 00168 Rome, Italy. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-ret, Databases, Genetic, Mutation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: The RET (Rearranged during Transfection) gene encodes a receptor tyrosine kinase. RET plays a critical role in embryonic development and postnatal physiology. This review provides a comprehensive overview of RET-associated disorders, focusing on the molecular mechanisms of RET activation, associated clinical phenotypes and therapeutic implications. In addition, we present an updated RET mutation database.
Methods
RET mutation database is built through the integration and curation of data from two major RET mutation repositories: the Leiden Open Variation Database (LOVD) and the Cancer Knowledge Base (CKB) as well as information derived from the ClinVar database.
Results
To date, 78 pathogenic RET mutations have been identified, among these, 71 (91.0%) are single nucleotide substitutions (missense variants), 2 (2.6%) are deletions, 1 (1.3%) are indels, 2 (2.6%) are nonsense mutations and 1 (1.3%) mutation affecting the introns. A pronounced clustering was observed in exons 10–11, accounting for ~60% of cases, suggesting a potential mutational hotspot with structural or functional relevance.
Conclusions
Aberrant RET activation, resulting from activating missense variants, gene fusions, or overexpression, underlies a wide spectrum of human diseases. These include multiple endocrine neoplasia type 2A (MEN2A), medullary thyroid carcinoma (MTC), Hirschsprung disease, and pheochromocytoma. The existence and use of a database classifying variants in the RET gene plays a fundamental role in molecular diagnostics and personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departmental Unit of Molecular and Genomic Diagnostics, Fondazione Policlinico Gemelli IRCCS, 00168 Rome, Italy.
- Genomics Core Facility, Gemelli Science and Technology Park (G-STeP), Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
- Department of Basic Biotechnological Sciences, Intensivological and Perioperative Clinics, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Departmental Unit of Chemistry, Biochemistry and Clinical Molecular Biology, Department of Diagnostic and Laboratory Medicine, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
ORCID-Profile: Giulia Maneri, Angelo Minucci
Zitieren
APA
Ricciardi Tenore, C., Tulli, E., Perrucci, A., Bertozzi, R., Fortuna, L., Maneri, G., Santonocito, C., Urbani, A., De Bonis, M., & Minucci, A. (2025). RET Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update. Genes, 16(12), 1472. https://doi.org/10.3390/genes16121472
Vancouver
Ricciardi Tenore C, Tulli E, Perrucci A, Bertozzi R, Fortuna L, Maneri G, et al. RET Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update. Genes. 2025;16(12):1472. doi:10.3390/genes16121472
BibTeX
@article{RicciardiTenore2025,
author = {Ricciardi Tenore, Claudio and Tulli, Eugenia and Perrucci, Alessia and Bertozzi, Roberto and Fortuna, Ludovica and Maneri, Giulia and Santonocito, Concetta and Urbani, Andrea and De Bonis, Maria and Minucci, Angelo},
title = {RET Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update},
journal = {Genes},
year = {2025},
volume = {16},
number = {12},
pages = {1472},
doi = {10.3390/genes16121472}
}
EUVIMED